Neue Suche | Kongressdetail
Druckansicht
 
 

Ligase Targeting Drug Development Summit - May 2021 - Digital Event

Evvnt Promotion / evvnt
Archiv
-
25.05.2021 - 27.05.2021  Online
Time: 08:30 - 17:00
 
Kongressthemen
As the therapeutic value of manipulating previously hard-to-drug ubiquitin ligases becomes more and more evident in addressing numerous diseases with unmet clinical needs, the inaugural Ligase Targeting Drug Development Summit arrives as the dedicated scientific and networking forum for large pharma, innovative biotech and research institutes to seize the day.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Speakers: Chris De Savi Vice President Head of Drug Discovery Kymera, Miklos Bekes Senior Research Investigator and Group Leader in Platform Biology Arvinas, Daniel Nomura Professor of Chemistry, University of California Berkeley and more.
 

Anfragen und Anmeldung:

https://go.evvnt.com/717315-2?pid=4832
Herr Customer Service
 
Kategorien
Allgemeinmedizin
Sprache
Englisch
Kongressgebühr
Conference Only: USD 1999.0, Conference + 1 Workshop: USD 2348.0, Conference + 2 Workshops: USD 2697.0
Teilnehmer erwartet
1000
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

Ärztekammer für WienAMREF - African Medical and Research FoundationCharité International AcademyEuropean Public Health Association (EUPHA)Österreichische Gesellschaft für Public HealthÖsterreichisches Rotes KreuzAlumni Club Medizinische Universität WienÖsterreichische Akademie der Ärzte